We are live on
!
Find out more
PCA
Peddock Capital Advisors Portfolio holdings
AUM
$453M
1-Year Est. Return
27.21%
This Fund
S&P 500
This Quarter
Est. Return
+2.36%
1 Year Est. Return
+27.21%
3 Year Est. Return
+95.53%
5 Year Est. Return
+149.52%
10 Year Est. Return
+326.66%
AUM
$188M
AUM Growth
+$15.3M
(+8.9%)
Cap. Flow
+$12.2M
Cap. Flow
% of AUM
6.5%
Top 10 Holdings %
Top 10 Hldgs %
55.08%
Holding
264
New
26
Increased
77
Reduced
16
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$1.52M |
| 3 |
HP
HPQ
|
+$856K |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$730K |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$521K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$502K |
| 2 |
iShares Select Dividend ETF
DVY
|
+$104K |
| 3 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$57.3K |
| 4 |
ExxonMobil
XOM
|
+$49.4K |
| 5 |
Perrigo
PRGO
|
+$38K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 38.96% |
| 2 | Technology | 8.94% |
| 3 | Healthcare | 8.21% |
| 4 | Financials | 7.81% |
| 5 | Consumer Staples | 6.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
ExxonMobil
XOM
$629B
| $65.1M | 34.56% |
806,245
-604
| -0.1% | -$49.4K |
|
2
Chevron
CVX
$381B
| $6.5M | 3.45% |
62,313
+454
| +0.7% | +$48.1K |
|
3
NVIDIA
NVDA
$5.02T
| $5.71M | 3.03% |
1,581,080
+1,920
| +0.1% | +$6.1K |
|
|
4
iShares Core S&P 500 ETF
IVV
$887B
| $5.23M | 2.78% |
21,475
+2,158
| +11% | +$521K |
|
|
5
iShares Core US Aggregate Bond ETF
AGG
$138B
| $4.5M | 2.39% |
41,099
+6,678
| +19% | +$730K |
|
6
Constellation Brands
STZ
$22.3B
| $4.19M | 2.23% |
21,645
+1,086
| +5% | +$193K |
|
7
Vanguard Small-Cap ETF
VB
$80B
| $3.53M | 1.88% |
26,072
+2,396
| +10% | +$321K |
|
8
iShares Floating Rate Bond ETF
FLOT
$10.1B
| $3.32M | 1.76% |
65,258
+10,093
| +18% | +$513K |
|
9
Apple
AAPL
$4.81T
| $2.93M | 1.56% |
81,396
+5,500
| +7% | +$203K |
|
10
Invesco S&P 500 Equal Weight ETF
RSP
$95.7B
| $2.72M | 1.45% |
29,384
+1,514
| +5% | +$139K |
|
11
JPMorgan Chase
JPM
$918B
| $2.36M | 1.25% |
25,805
+441
| +2% | +$38.1K |
|
|
CELG
12
DELISTED
Celgene Corp
CELG
| $1.85M | 0.98% |
14,231
+396
| +3% | +$48.5K |
|
13
Altria Group
MO
$122B
| $1.8M | 0.95% |
24,136
| – | – |
|
|
AGN
14
DELISTED
Allergan plc
AGN
| $1.72M | 0.91% |
+7,067
| New | +$1.66M |
|
15
iShares Russell 2000 ETF
IWM
$82.4B
| $1.7M | 0.9% |
12,068
-228
| -2% | -$31.6K |
|
|
FISV
16
Fiserv Inc
FISV
$27B
| $1.67M | 0.89% |
27,346
+310
| +1% | +$18.8K |
|
17
Unum
UNM
$14.1B
| $1.67M | 0.89% |
35,825
+237
| +0.7% | +$10.9K |
|
18
McKesson
MCK
$97B
| $1.67M | 0.89% |
10,144
+268
| +3% | +$40.6K |
|
19
Thermo Fisher Scientific
TMO
$195B
| $1.54M | 0.82% |
8,836
+1,227
| +16% | +$206K |
|
|
20
Alphabet (Google) Class C
GOOG
$4.22T
| $1.54M | 0.82% |
+33,120
| New | +$1.52M |
|
21
Bank of America
BAC
$430B
| $1.48M | 0.79% |
61,179
+2,049
| +3% | +$47.8K |
|
22
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
| $1.44M | 0.77% |
18,013
+2,780
| +18% | +$222K |
|
23
McDonald's
MCD
$188B
| $1.41M | 0.75% |
9,211
-81
| -0.9% | -$11.7K |
|
24
Pfizer
PFE
$142B
| $1.39M | 0.74% |
43,606
| – | – |
|
25
CVS Health
CVS
$141B
| $1.26M | 0.67% |
15,690
+549
| +4% | +$43.3K |
|
Similar funds
VV
FNB
ATI
MCM
BWM
CFG
AA
TPWM
Peddock Capital Advisors's Q2 2017 Portfolio in Review
As of Q2 2017, Peddock Capital Advisors held 264 positions worth $188M, up 8.9% from $173M the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Peddock Capital Advisors deployed $12.2M of net new capital in Q2 2017, opening 26 new positions and adding to 77 existing holdings. Its largest new stake was Allergan plc: 7,067 shares worth $1.72M.
By sector, the portfolio is most concentrated in Energy at 39% of assets, down from 43% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Procter & Gamble, an estimated $502K trimmed.
- Peddock Capital Advisors's largest Q2 2017 buy was Allergan plc: 7,067 shares worth $1.72M.
- Peddock Capital Advisors added most to iShares Core US Aggregate Bond ETF in Q2 2017, an estimated $730K increase.
- Peddock Capital Advisors's biggest Q2 2017 reduction was Procter & Gamble, cutting an estimated $502K.
- Peddock Capital Advisors fully exited Perrigo in Q2 2017, selling an estimated $38K.
- Peddock Capital Advisors's ten largest holdings make up 55% of its $188M portfolio in Q2 2017.
- Peddock Capital Advisors opened 26 new positions and closed 11 in Q2 2017.
- Peddock Capital Advisors's portfolio value rose 8.9% quarter-over-quarter to $188M.
Based on Peddock Capital Advisors's 13F filing for Q2 2017, filed 4 Aug 2017.